National Institute of Mental Health; Notice of Meeting, 38713-38714 [2018-16794]

Download as PDF daltland on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices Guy by email: guyr2@niehs.nih.gov by August 29, 2018. Meeting Materials: The preliminary meeting agenda is available on the meeting web page https:// ntp.niehs.nih.gov/go/32822 and will be updated one week before the meeting. Individuals are encouraged to access the meeting web page to stay abreast of the most current information regarding the meeting. Background Information on ICCVAM, NICEATM, and SACATM: ICCVAM is an interagency committee composed of representatives from 16 federal regulatory and research agencies that require, use, generate, or disseminate toxicological and safety testing information. ICCVAM conducts technical evaluations of new, revised, and alternative safety testing methods with regulatory applicability and promotes the scientific validation and regulatory acceptance of toxicological and safety-testing methods that more accurately assess the safety and hazards of chemicals and products and that reduce, refine (decrease or eliminate pain and distress), or replace animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3) established ICCVAM as a permanent interagency committee of the NIEHS under NICEATM. NICEATM administers ICCVAM, provides scientific and operational support for ICCVAM-related activities, and conducts independent validation studies to assess the usefulness and limitations of new, revised, and alternative test methods and strategies. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods and strategies applicable to the needs of U.S. federal agencies. NICEATM and ICCVAM welcome the public nomination of new, revised, and alternative test methods and strategies for validation studies and technical evaluations. Additional information about ICCVAM and NICEATM can be found at https:// ntp.niehs.nih.gov/go/iccvam and https:// ntp.niehs.nih.gov/go/niceatm. SACATM was established in response to the ICCVAM Authorization Act [Section 285l–3(d)] and is composed of scientists from the public and private sectors. SACATM advises ICCVAM, NICEATM, and the Director of the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and activities of NICEATM. SACATM provides advice on priorities and activities related to the development, validation, scientific review, regulatory acceptance, implementation, and national and international VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 harmonization of new, revised, and alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/ 167. Dated: July 24, 2018. Brian R. Berridge, Associate Director, National Toxicology Program. [FR Doc. 2018–16840 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Autism Coordinating Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of Meeting: Open Meeting. Date: Wednesday, October 17, 2018. Time: 9:00 a.m. to 5:00 p.m. *Eastern Time* Approximate end time. Agenda: To discuss business, updates, and issues related to ASD research and services activities. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C and D, Rockville, MD 20852. Webcast Live: https://videocast.nih.gov. Conference Call Access: Dial: 800–369– 3190. Access Code: 1724926. Cost: The meeting is free and open to the public. Registration: A registration web link will be posted on the IACC website (www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis. Onsite registration will also be available. Deadlines: Notification of interest to present oral comments: Friday, October 5, 2018 by 5:00 p.m. ET Submission of written/electronic statement for oral comments: Tuesday, October 9, 2018 by 5:00 p.m. ET Submission of written comments: Tuesday, October 9, 2018 by 5:00 p.m. ET PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 38713 For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/ public-comments/guidelines/ Access: White Flint Metro Station (Red Line) in combination with a brief walk. Contact Person: Ms. Angelice Mitrakas, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Room 6182A, Bethesda, MD 20892–9669, Phone: 301–435– 9269, Email: IACCPublicInquiries@ mail.nih.gov. Public Comments: Any member of the public interested in presenting oral comments to the IACC must notify the Contact Person listed on this notice by 5:00 p.m. ET on Friday, October 5, 2018 with their request to present oral comments at the meeting, and a written/ electronic copy of the oral presentation/ statement must be submitted by 5:00 p.m. ET on Tuesday, October 9, 2018. A limited number of slots for oral comment are available, and in order to ensure that as many different individuals are able to present throughout the year as possible, any given individual only will be permitted to present oral comments once per calendar year (2018). Only one representative of an organization will be allowed to present oral comments in any given meeting; other representatives of the same group may provide written comments. If the oral comment session is full, individuals who could not be accommodated are welcome to provide written comments instead. Comments to be read or presented in the meeting will be assigned a 3–5 minute time slot depending on the number of comments, but a longer version may be submitted in writing for the record. Commenters going beyond their allotted time in the meeting may be asked to conclude immediately in order to allow other comments and presentations to proceed on schedule. Any interested person may submit written public comments to the IACC prior to the meeting by emailing the comments to IACCPublicInquiries@ mail.nih.gov or by submitting comments at the web link: https://iacc.hhs.gov/ meetings/public-comments/submit/ index.jsp by 5:00 p.m. ET on Tuesday, October 9, 2018. The comments should include the name, address, telephone number, and when applicable, the business or professional affiliation of the interested person. National Institute on Mental Health (NIMH) anticipates written public comments received by 5:00 p.m. ET on Tuesday, October 9, 2018 will be presented to the IACC prior to the meeting for the IACC’s consideration. Any written comments received after the 5:00 p.m. ET, October 9, 2018 deadline through October 15, E:\FR\FM\07AUN1.SGM 07AUN1 daltland on DSKBBV9HB2PROD with NOTICES 38714 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 2018 will be provided to the IACC either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. All written public comments and oral public comment statements received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. In the 2016–2017 IACC Strategic Plan, the IACC listed the ‘‘Spirit of Collaboration’’ as one of its core values, stating that, ‘‘We will treat others with respect, listen with open minds to the diverse views of people on the autism spectrum and their families, thoughtfully consider community input, and foster discussions where participants can comfortably where participants can comfortably offer opposing opinions.’’ In keeping with this core value, the IACC and the NIMH Office of Autism Research Coordination ask that members of the public who provide public comments or participate in meetings of the IACC also seek to treat others with respect and consideration in their communications and actions, even when discussing issues of genuine concern or disagreement. Remote Access: The meeting will be open to the public through a conference call phone number and webcast live on the internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the webcast or conference call, please send an e- mail to IACCPublicInquiries@ mail.nih.gov or call 240–668–0302. Individuals wishing to participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least five days prior to the meeting. Security: Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Also, as a part of security procedures, attendees should be prepared to present a photo ID at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 on a first come, first served basis, with expedited check-in for those who are pre-registered. Meeting schedule subject to change. Information about the IACC is available on the website: https://www.iacc.hhs.gov. Dated: August 1, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16794 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the meeting of the Council of Councils. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast. nih.gov). A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Council of Councils. Open: September 7, 2018. Time: 8:15 a.m. to 12:15 p.m. Agenda: Call to Order and Introductions; Announcements and Updates; Environmental influences on Child Health Outcomes (ECHO), Program Genetics and Epigenetics Research to be Supported by Future ECHO Genetics Core; All of Us Research Program Update; NIH Update; Common Fund Program—Stimulating Peripheral Activity to Address Conditions. Place: National Institutes of Health, 9000 Rockville Pike, Building 60/Cloisters, Lecture Hall/Chapel, Bethesda, MD 20892. Closed: September 7, 2018. Time: 12:25 p.m. to 1:25 p.m. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Agenda: Review of Grant Applications. Place: National Institutes of Health, 9000 Rockville Pike, Building 60/Cloisters, Lecture Hall/Chapel, Bethesda, MD 20892. Open: September 7, 2018. Time: 1:25 p.m. to 4:30 p.m. Agenda: Council Operating Procedures; Workshop Report on Contributions of Social and Behavioral Research in Addressing the Opioid Crisis; Retiring Council Members’ Perspectives. Place: National Institutes of Health, 9000 Rockville Pike, Building 60/Cloisters, Lecture Hall/Chapel, Bethesda, MD 20892. Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive Secretary, Council of Councils Director, Office of Research Infrastructure Programs, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 6701 Democracy Boulevard, Room 948, Bethesda, MD 20892, GriederF@mail.nih.gov, 301–435– 0744. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Council of Council’s home page at https:// dpcpsi.nih.gov/council/ where an agenda will be posted before the meeting date. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: August 1, 2018. David D. Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16792 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38713-38714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16794]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Interagency Autism 
Coordinating Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Type of Meeting: Open Meeting.
    Date: Wednesday, October 17, 2018.
    Time: 9:00 a.m. to 5:00 p.m. *Eastern Time* Approximate end 
time.
    Agenda: To discuss business, updates, and issues related to ASD 
research and services activities.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Conference Room C and D, Rockville, MD 20852.
    Webcast Live: https://videocast.nih.gov.
    Conference Call Access: Dial: 800-369-3190.
    Access Code: 1724926.
    Cost: The meeting is free and open to the public.
    Registration: A registration web link will be posted on the IACC 
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is 
recommended to expedite check-in. Seating in the meeting room is 
limited to room capacity and on a first come, first served basis. 
Onsite registration will also be available.
    Deadlines: Notification of interest to present oral comments: 
Friday, October 5, 2018 by 5:00 p.m. ET
    Submission of written/electronic statement for oral comments: 
Tuesday, October 9, 2018 by 5:00 p.m. ET
    Submission of written comments: Tuesday, October 9, 2018 by 5:00 
p.m. ET
    For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/
    Access: White Flint Metro Station (Red Line) in combination with 
a brief walk.
    Contact Person: Ms. Angelice Mitrakas, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone: 
301-435-9269, Email: [email protected].

    Public Comments: Any member of the public interested in presenting 
oral comments to the IACC must notify the Contact Person listed on this 
notice by 5:00 p.m. ET on Friday, October 5, 2018 with their request to 
present oral comments at the meeting, and a written/electronic copy of 
the oral presentation/statement must be submitted by 5:00 p.m. ET on 
Tuesday, October 9, 2018. A limited number of slots for oral comment 
are available, and in order to ensure that as many different 
individuals are able to present throughout the year as possible, any 
given individual only will be permitted to present oral comments once 
per calendar year (2018). Only one representative of an organization 
will be allowed to present oral comments in any given meeting; other 
representatives of the same group may provide written comments. If the 
oral comment session is full, individuals who could not be accommodated 
are welcome to provide written comments instead. Comments to be read or 
presented in the meeting will be assigned a 3-5 minute time slot 
depending on the number of comments, but a longer version may be 
submitted in writing for the record. Commenters going beyond their 
allotted time in the meeting may be asked to conclude immediately in 
order to allow other comments and presentations to proceed on schedule.
    Any interested person may submit written public comments to the 
IACC prior to the meeting by emailing the comments to 
[email protected] or by submitting comments at the web 
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by 
5:00 p.m. ET on Tuesday, October 9, 2018. The comments should include 
the name, address, telephone number, and when applicable, the business 
or professional affiliation of the interested person. National 
Institute on Mental Health (NIMH) anticipates written public comments 
received by 5:00 p.m. ET on Tuesday, October 9, 2018 will be presented 
to the IACC prior to the meeting for the IACC's consideration. Any 
written comments received after the 5:00 p.m. ET, October 9, 2018 
deadline through October 15,

[[Page 38714]]

2018 will be provided to the IACC either before or after the meeting, 
depending on the volume of comments received and the time required to 
process them in accordance with privacy regulations and other 
applicable Federal policies. All written public comments and oral 
public comment statements received by the deadlines for both oral and 
written public comments will be provided to the IACC for their 
consideration and will become part of the public record. Attachments of 
copyrighted publications are not permitted, but web links or citations 
for any copyrighted works cited may be provided.
    In the 2016-2017 IACC Strategic Plan, the IACC listed the ``Spirit 
of Collaboration'' as one of its core values, stating that, ``We will 
treat others with respect, listen with open minds to the diverse views 
of people on the autism spectrum and their families, thoughtfully 
consider community input, and foster discussions where participants can 
comfortably where participants can comfortably offer opposing 
opinions.'' In keeping with this core value, the IACC and the NIMH 
Office of Autism Research Coordination ask that members of the public 
who provide public comments or participate in meetings of the IACC also 
seek to treat others with respect and consideration in their 
communications and actions, even when discussing issues of genuine 
concern or disagreement.
    Remote Access: The meeting will be open to the public through a 
conference call phone number and webcast live on the internet. Members 
of the public who participate using the conference call phone number 
will be able to listen to the meeting but will not be heard. If you 
experience any technical problems with the webcast or conference call, 
please send an e- mail to [email protected] or call 240-
668-0302.
    Individuals wishing to participate in person or by using these 
electronic services and who need special assistance, such as captioning 
of the conference call or other reasonable accommodations, should 
submit a request to the Contact Person listed on this notice at least 
five days prior to the meeting.
    Security: Visitors will be asked to show one form of identification 
(for example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit. Also, as a part of 
security procedures, attendees should be prepared to present a photo ID 
at the meeting registration desk during the check-in process. Pre-
registration is recommended. Seating will be limited to the room 
capacity and seats will be on a first come, first served basis, with 
expedited check-in for those who are pre-registered.
    Meeting schedule subject to change. Information about the IACC is 
available on the website: https://www.iacc.hhs.gov.

    Dated: August 1, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16794 Filed 8-6-18; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.